Beam Therapeutics (BEAM) Enterprise Value (2019 - 2026)
Beam Therapeutics (BEAM) reported Enterprise Value of -$1.2 billion for Q1 2026, up 0.68% year-over-year from -$1.2 billion in Q1 2025, and up 2.69% on a QoQ basis from -$1.2 billion in Q4 2025.
Beam Therapeutics (BEAM) has 8 years of Enterprise Value data on file, last reported at -$1.2 billion in Q1 2026.
- Quarterly Enterprise Value rose 0.68% year-over-year to -$1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.2 billion (up 0.68% YoY) and the FY2025 annual result came in at -$1.2 billion, down 46.37% from the prior year.
- Enterprise Value improved to -$1.2 billion in Q1 2026 per BEAM's latest filing, from -$1.2 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$156.5 million in Q3 2022 and bottomed at -$1.2 billion in Q4 2025.
- The 5-year median for Enterprise Value is -$1.1 billion (2023), against an average of -$936.2 million.
- The widest annual swing landed in 2022, when Enterprise Value soared 83.23%; it then sank 548.81% in 2023.
- Tracing BEAM's Enterprise Value over 5 years: stood at -$1.1 billion in 2022, then retreated by 10.36% to -$1.2 billion in 2023, then gained by 28.5% to -$850.7 million in 2024, then slumped by 46.37% to -$1.2 billion in 2025, then gained by 2.69% to -$1.2 billion in 2026.
- Per Business Quant, the three latest BEAM Enterprise Value figures stand at -$1.2 billion (Q1 2026), -$1.2 billion (Q4 2025), and -$1.1 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Beam Therapeutics | 3.40 Bn | 3.40 Bn | - | -1.21 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.21 Bn |
| Dec 31, 2025 | -1.25 Bn |
| Sep 30, 2025 | -1.07 Bn |
| Jun 30, 2025 | -1.15 Bn |
| Mar 31, 2025 | -1.22 Bn |
| Dec 31, 2024 | -850.74 Mn |
| Sep 30, 2024 | -925.76 Mn |
| Jun 30, 2024 | -1.01 Bn |
| Mar 31, 2024 | -1.09 Bn |
| Dec 31, 2023 | -1.19 Bn |
| Sep 30, 2023 | -1.02 Bn |
| Jun 30, 2023 | -1.07 Bn |
| Mar 31, 2023 | -1.06 Bn |
| Dec 31, 2022 | -1.08 Bn |
| Sep 30, 2022 | -156.51 Mn |
| Jun 30, 2022 | -265.62 Mn |
| Mar 31, 2022 | -296.82 Mn |
| Dec 31, 2021 | -559.99 Mn |
| Sep 30, 2021 | -933.41 Mn |
| Jun 30, 2021 | -615.28 Mn |
| Mar 31, 2021 | -503.48 Mn |
| Dec 31, 2020 | -299.67 Mn |
| Sep 30, 2020 | -202.22 Mn |
| Jun 30, 2020 | -227.95 Mn |
| Mar 31, 2020 | -253.44 Mn |
| Dec 31, 2019 | -91.85 Mn |
| Sep 30, 2019 | -37.76 Mn |
| Jun 30, 2019 | -37.85 Mn |
| Mar 31, 2019 | -156.14 Mn |